United Press International - Friday, 22 June 2001
Rodolfo A. Windhausen
As a novelty, the special meeting will include -- along with government delegates and heads of state -- a large number of representatives from pharmaceutical and chemical companies, as well as lobbyists, religious leaders and non-governmental organizations. The session has been configured to be held in panels, to which the press will have free access.
Analysts are expecting a big show of force, with strong demands from underdeveloped countries for less expensive access to drugs to combat the pandemic and the right to bend international rules on patents in order to produce cheaper anti-AIDS medication.
Also expected is a heated confrontation between religious groups, especially Catholics and Muslims, who have expressed opposition to some prevention programs and sex education policies currently being implemented internationally by U.N. agencies and individual governments.
In a report released this week, the Joint U.N. Program on HIV/AIDS (UNAIDS) pointed out that treating millions of people already infected with HIV will cost $9.2 billion annually, of which developing nations are expected to contribute a third to a half, with the industrialized countries providing the rest.
About $1.8 billion is now being spent on AIDS treatment and prevention programs in the developing world, which is less than a fifth of the projected need, according to estimates from U.N. Secretary-General Kofi Annan.
Since it first appeared about 20 years ago, AIDS has killed some 22 million people around the world. The worst situation is in sub-Saharan nations, which are among the poorest in the world and have fewer resources to combat the disease.
A group of developing countries, informally led by Brazil, South Africa and India, has proposed the production of cheaper, more accessible drugs that are copied from patented medication produced by the industrialized world.
In a statement issued a few days ago in Geneva, they asked for the right to bend the strict patent protection rules of a 1994 international trade treaty, known as TRIPS, in the event of a national health emergency such as the AIDS pandemic.
Rich nations -- in which most of the largest pharmaceutical companies are based -- have warned that weakening the patent protection regulations contained in TRIPS would undermine the efforts made by those companies in researching an effective cure for the disease.
The U.S. government maintains that, without the economic incentives provided by the patents system, "fewer drugs will be available for treating fatal diseases."
Observers have noted, however, that many leading U.S. and European pharmaceutical companies are feeling the pressure and giving in to the demands from Third World countries, especially from Africa, to lower the price of anti-AIDS drugs.
Disputes over treatment and prevention of HIV/AIDS are also likely to produce some noisy clashes during the deliberations, according to analysts and U.N. officials.
Conservative Islamic countries, the Catholic Church and some other Christian groups have already expressed firm opposition to the distribution of condoms, the dissemination of information on safe sex and the use of contraceptive methods to prevent the spread of the disease.
An Egyptian delegate has already proposed that the final document include a reference to homosexuality as one of the leading causes of spreading infections, a view that is strongly opposed by pro-gay activists.
Libya, in turn, is opposing any mention of narcotics in the statement, which is expected to be issued at the end of the two-day session.
Feminist issues will also be in the agenda. The U.N. Development Fund for Women, known as UNIFEM, has announced a five-point plan of action "to make women central to every strategy in the fight against HIV/AIDS."
Citing the fact that 1.3 million women died of AIDS last year and that nearly half of new HIV infections affect women, UNIFEM has proposed making male and female condoms "affordable and accessible to all" and the dissemination of AIDS prevention information to adolescents and women who, it claims, "should be involved in the design of policies and education campaigns."
To emphasize the U.N.'s commitment to the issue, the U.N. Secretariat Building in New York will display a huge red AIDS ribbon stretched over 550 of its windows during the deliberations.
010622
UP010632
Copyright © 2001 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .